Labetalol: Difference between revisions
No edit summary |
|||
| Line 14: | Line 14: | ||
Cardiovascular Drugs:Beta blockers | Cardiovascular Drugs:Beta blockers | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
=== | ===Labetalol Hydrochloride injection=== | ||
'''| [[Labetalol injection indications and usage|Indications and Usage]]''' | '''| [[Labetalol injection indications and usage|Indications and Usage]]''' | ||
| Line 28: | Line 28: | ||
'''| [[Labetalol injection clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Labetalol injection clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Labetalol injection nonclinical toxicology|Nonclinical Toxicology]]''' | '''| [[Labetalol injection nonclinical toxicology|Nonclinical Toxicology]]''' | ||
'''| [[Labetalol injection how supplied storage and handling|How Supplied/Storage and Handling]]''' | '''| [[Labetalol injection how supplied storage and handling|How Supplied/Storage and Handling]]''' | ||
'''| [[Labetalol injection patient counseling information|Patient Counseling Information]]''' | '''| [[Labetalol injection patient counseling information|Patient Counseling Information]]''' | ||
'''| [[Labetalol injection labels and packages|Labels and Packages]]''' | '''| [[Labetalol injection labels and packages|Labels and Packages]]''' | ||
=== | ===Labetalol Hydrochloride tablet=== | ||
| Line 48: | Line 47: | ||
'''| [[Labetalol tablet clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Labetalol tablet clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Labetalol tablet nonclinical toxicology|Nonclinical Toxicology]]''' | '''| [[Labetalol tablet nonclinical toxicology|Nonclinical Toxicology]]''' | ||
'''| [[Labetalol tablet how supplied storage and handling|How Supplied/Storage and Handling]]''' | '''| [[Labetalol tablet how supplied storage and handling|How Supplied/Storage and Handling]]''' | ||
'''| [[Labetalol tablet patient counseling information|Patient Counseling Information]]''' | '''| [[Labetalol tablet patient counseling information|Patient Counseling Information]]''' | ||
Revision as of 20:39, 5 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
For patient information about Labetalol, click here
Synonyms / Brand Names:
Overview
Labetalol (Normodyne, Trandate, fixed combination with hydrochlorothiazide: Normozyde) is an alpha-1 andbeta adrenergic blocker used to treat high blood pressure. It works by blocking these adrenergic receptors, which slows sinus heart rate, decreases peripheral vascular resistance.
It has a particular indication in the treatment of pregnancy-induced hypertension.
Category
Cardiovascular Drugs:Beta blockers
FDA Package Insert
Labetalol Hydrochloride injection
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Labetalol Hydrochloride tablet
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages